Cargando…
Pharmacokinetics and Pharmacodynamics of ASKP1240, a Fully Human Anti-CD40 Antibody, in Normal and Renal Transplanted Cynomolgus Monkeys
BACKGROUND: The purpose of this study was to evaluate the serum concentration of ASKP1240 (pharmacokinetics [PK]) and the CD40 occupancy of ASKP1240 (pharmacodynamics [PD]) in normal and renal transplanted Cynomolgus monkeys to clarify the PK/PD relationship. METHODS: In a 70-day study, two ASKP1240...
Autores principales: | Ma, Anlun, Dun, Hao, Song, Lijun, Hu, Yanxin, Zeng, Lin, Bai, Jieying, Zhang, Guangzhou, Kinugasa, Fumitaka, Miyao, Yasuhiro, Sakuma, Shozo, Okimura, Kazumichi, Kasai, Noriyuki, Daloze, Pierre, Chen, Huifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979827/ https://www.ncbi.nlm.nih.gov/pubmed/24389907 http://dx.doi.org/10.1097/01.TP.0000440951.29757.bd |
Ejemplares similares
-
Effects of ASKP1240 Combined With Tacrolimus or Mycophenolate Mofetil on Renal Allograft Survival in Cynomolgus Monkeys
por: Song, Lijun, et al.
Publicado: (2014) -
Characterization of ASKP1240, a Fully Human Antibody Targeting Human CD40 With Potent Immunosuppressive Effects
por: Okimura, K, et al.
Publicado: (2014) -
Randomized, controlled study of bleselumab (ASKP1240) pharmacokinetics and safety in patients with moderate‐to‐severe plaque psoriasis
por: Anil Kumar, Mysore S., et al.
Publicado: (2018) -
Comparative pharmacokinetics and pharmacodynamics of the advanced Retinol-Binding Protein 4 antagonist in dog and cynomolgus monkey
por: Racz, Boglarka, et al.
Publicado: (2020) -
Keratoconus in a Cynomolgus Monkey
por: Kodama, Rinya, et al.
Publicado: (2010)